Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 5.0
Power Rank trend -> Rising
Industry: Biotechnology
Follow @stockchartsai on TwitterIn the past 20 trading days, CRSP has been trading in a range between $62.75 and $53.10 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
CRSP is trading between resistance at $62.08 about 7% to the upside and support at $56.22 -3% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $66.83, about a 15% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Crispr Therapeutics AG $CRSP entered a Green zone 2 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $88.13, a potential upside of 52.16% from the recent price of 57.92. The stock is trading 57.29% (potential upside) below its 52 week high of $91.10 and 54.25 % (potential downside) above its 52 week low of $37.55 - based on the recent price.
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, immune-oncology and autoimmune, in vivo, and type 1 diabetes.
CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $57.92, signifying a +0.61% move from its prior day's close. Source: Zacks Investment Research Fri, 26 Jul 2024 18:56:39 -0400 Sentiment: Neutral |
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know CRISPR Therapeutics AG (CRSP) closed at $57.19 in the latest trading session, marking a +1.69% move from the prior day. Source: Zacks Investment Research Tue, 23 Jul 2024 19:06:10 -0400 Sentiment: Negative |
Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings? On CRISPR Therapeutics' (CRSP) second-quarter 2024 earnings call, investors' focus is likely to be on the sales numbers of its newly approved gene therapy, Casgevy, and other pipeline updates. Source: Zacks Investment Research Tue, 23 Jul 2024 10:51:18 -0400 Sentiment: Neutral |
3 Gene Editing Stocks Shaping the Future of Medicine Gene editing stocks represent one of the biggest investing trends in biopharma in recent years. The gene editing field employs advanced technologies to edit the DNA of different organisms, thereby opening up possibilities for transformative treatment options. Source: InvestorPlace Mon, 22 Jul 2024 16:45:00 -0400 Sentiment: Neutral |
3 Monster Stocks in the Making to Buy Right Now CRISPR Therapeutics now has its first product on the market. Zealand Pharma has two promising candidates targeting the huge obesity and MASH/NASH markets. Source: The Motley Fool Sat, 20 Jul 2024 06:00:00 -0400 Sentiment: Positive |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.